Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Unable to match target stats. Using MCMLE estimation.
Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.523340285019344.
The log-likelihood improved by 2.661.
Iteration 2 of at most 500:
Optimizing with step length 0.650595263138806.
The log-likelihood improved by 3.231.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.4132.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.2344.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       7       27     1222     1068      766      351      379      377 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     295      207      128       76       52       25       13        3 
degree16 degree18 
       3        1 
1 
disease_progression 
H-positive risk:  844 867 117 879 448 122 855 475 133 52 137 71 
H-negative risk:  867 844 855 879 475 448 122 117 137 133 71 52 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
59 new agents 
2 
disease_progression 
H-positive risk:  845 871 116 880 448 122 862 469 130 51 136 70 
H-negative risk:  871 845 862 880 469 448 122 116 136 130 70 51 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
66 new agents 
3 
disease_progression 
H-positive risk:  853 872 119 876 443 123 861 463 132 50 139 69 
H-negative risk:  872 853 861 876 463 443 123 119 139 132 69 50 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
59 new agents 
4 
disease_progression 
H-positive risk:  856 880 120 880 439 123 862 458 128 49 137 68 
H-negative risk:  880 856 862 880 458 439 123 120 137 128 68 49 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
60 new agents 
5 
disease_progression 
H-positive risk:  866 881 119 873 437 125 863 454 130 48 139 65 
H-negative risk:  881 866 863 873 454 437 125 119 139 130 65 48 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 7 

clinical_engagement 
diagnosis 
demography 
60 new agents 
6 
disease_progression 
H-positive risk:  869 885 120 865 435 126 860 454 133 47 141 65 
H-negative risk:  885 869 860 865 454 435 126 120 141 133 65 47 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 9 

clinical_engagement 
diagnosis 
demography 
46 new agents 
7 
disease_progression 
H-positive risk:  875 887 122 863 425 126 858 458 132 47 142 65 
H-negative risk:  887 875 858 863 458 425 126 122 142 132 65 47 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 11 

clinical_engagement 
diagnosis 
demography 
47 new agents 
8 
disease_progression 
H-positive risk:  878 892 122 862 429 127 851 452 133 47 141 66 
H-negative risk:  892 878 851 862 452 429 127 122 141 133 66 47 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 14 

clinical_engagement 
diagnosis 
demography 
57 new agents 
9 
disease_progression 
H-positive risk:  885 896 122 855 431 129 851 444 134 48 142 63 
H-negative risk:  896 885 851 855 444 431 129 122 142 134 63 48 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
10 
disease_progression 
H-positive risk:  888 908 122 861 428 128 848 435 134 47 142 59 
H-negative risk:  908 888 848 861 435 428 128 122 142 134 59 47 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
11 
disease_progression 
H-positive risk:  890 910 121 861 423 128 849 441 133 42 144 58 
H-negative risk:  910 890 849 861 441 423 128 121 144 133 58 42 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 16 

clinical_engagement 
diagnosis 
demography 
55 new agents 
12 
disease_progression 
H-positive risk:  901 913 120 863 416 127 843 436 137 42 144 58 
H-negative risk:  913 901 843 863 436 416 127 120 144 137 58 42 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 18 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
13 
disease_progression 
H-positive risk:  818 832 105 949 417 114 929 428 150 43 159 56 
H-negative risk:  832 818 929 949 428 417 114 105 159 150 56 43 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 19 2 

clinical_engagement 
diagnosis 
demography 
209 new agents 
14 
disease_progression 
H-positive risk:  848 853 107 925 426 119 888 436 144 43 150 61 
H-negative risk:  853 848 888 925 436 426 119 107 150 144 61 43 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 24 3 

clinical_engagement 
diagnosis 
demography 
57 new agents 
15 
disease_progression 
H-positive risk:  851 857 106 922 423 119 886 437 147 43 148 61 
H-negative risk:  857 851 886 922 437 423 119 106 148 147 61 43 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 25 4 

clinical_engagement 
diagnosis 
demography 
55 new agents 
16 
disease_progression 
H-positive risk:  860 857 107 920 421 119 888 433 146 42 145 62 
H-negative risk:  857 860 888 920 433 421 119 107 145 146 62 42 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 29 4 

clinical_engagement 
diagnosis 
demography 
56 new agents 
17 
disease_progression 
H-positive risk:  865 865 107 922 409 119 887 436 144 42 141 63 
H-negative risk:  865 865 887 922 436 409 119 107 141 144 63 42 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 31 5 

clinical_engagement 
diagnosis 
demography 
56 new agents 
18 
disease_progression 
H-positive risk:  868 864 106 915 405 120 887 442 148 43 141 61 
H-negative risk:  864 868 887 915 442 405 120 106 141 148 61 43 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 31 6 

clinical_engagement 
diagnosis 
demography 
60 new agents 
19 
disease_progression 
H-positive risk:  879 872 107 903 396 122 886 441 147 44 141 62 
H-negative risk:  872 879 886 903 441 396 122 107 141 147 62 44 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 31 6 

clinical_engagement 
diagnosis 
demography 
47 new agents 
20 
disease_progression 
H-positive risk:  881 875 107 904 391 124 885 438 147 44 140 64 
H-negative risk:  875 881 885 904 438 391 124 107 140 147 64 44 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 35 6 

clinical_engagement 
diagnosis 
demography 
54 new agents 
21 
disease_progression 
H-positive risk:  889 874 108 900 391 123 889 434 146 43 140 63 
H-negative risk:  874 889 889 900 434 391 123 108 140 146 63 43 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 37 5 

clinical_engagement 
diagnosis 
demography 
75 new agents 
22 
disease_progression 
H-positive risk:  888 878 110 906 381 125 888 435 146 41 138 64 
H-negative risk:  878 888 888 906 435 381 125 110 138 146 64 41 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 40 5 

clinical_engagement 
diagnosis 
demography 
72 new agents 
23 
disease_progression 
H-positive risk:  893 886 109 901 385 127 881 432 144 41 138 63 
H-negative risk:  886 893 881 901 432 385 127 109 138 144 63 41 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 42 5 

clinical_engagement 
diagnosis 
demography 
70 new agents 
24 
disease_progression 
H-positive risk:  897 896 109 899 385 127 876 429 146 41 136 59 
H-negative risk:  896 897 876 899 429 385 127 109 136 146 59 41 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 44 6 

clinical_engagement 
diagnosis 
demography 
63 new agents 
25 
disease_progression 
H-positive risk:  829 823 98 974 386 117 948 428 150 43 147 57 
H-negative risk:  823 829 948 974 428 386 117 98 147 150 57 43 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 44 7 

clinical_engagement 
diagnosis 
demography 
188 new agents 
26 
disease_progression 
H-positive risk:  860 849 103 931 415 119 907 431 145 47 129 64 
H-negative risk:  849 860 907 931 431 415 119 103 129 145 64 47 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 51 7 

clinical_engagement 
diagnosis 
demography 
73 new agents 
27 
disease_progression 
H-positive risk:  868 858 103 924 412 119 905 426 147 46 126 66 
H-negative risk:  858 868 905 924 426 412 119 103 126 147 66 46 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 52 8 

clinical_engagement 
diagnosis 
demography 
58 new agents 
28 
disease_progression 
H-positive risk:  872 864 105 919 403 119 906 421 148 48 129 66 
H-negative risk:  864 872 906 919 421 403 119 105 129 148 66 48 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 51 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
29 
disease_progression 
H-positive risk:  872 866 109 920 395 120 912 412 151 48 130 65 
H-negative risk:  866 872 912 920 412 395 120 109 130 151 65 48 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 52 7 

clinical_engagement 
diagnosis 
demography 
65 new agents 
30 
disease_progression 
H-positive risk:  872 870 114 912 398 122 913 405 152 49 127 66 
H-negative risk:  870 872 913 912 405 398 122 114 127 152 66 49 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 52 7 

clinical_engagement 
diagnosis 
demography 
53 new agents 
31 
disease_progression 
H-positive risk:  871 879 113 904 400 122 919 401 152 48 126 65 
H-negative risk:  879 871 919 904 401 400 122 113 126 152 65 48 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 53 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
32 
disease_progression 
H-positive risk:  872 887 114 900 399 121 920 394 154 48 126 65 
H-negative risk:  887 872 920 900 394 399 121 114 126 154 65 48 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 52 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
33 
disease_progression 
H-positive risk:  876 890 114 899 398 122 919 388 153 49 127 65 
H-negative risk:  890 876 919 899 388 398 122 114 127 153 65 49 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 54 7 

clinical_engagement 
diagnosis 
demography 
64 new agents 
34 
disease_progression 
H-positive risk:  883 890 117 900 397 123 921 381 151 48 125 64 
H-negative risk:  890 883 921 900 381 397 123 117 125 151 64 48 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 56 8 

clinical_engagement 
diagnosis 
demography 
45 new agents 
35 
disease_progression 
H-positive risk:  885 894 117 903 393 124 922 375 151 48 126 62 
H-negative risk:  894 885 922 903 375 393 124 117 126 151 62 48 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 58 9 

clinical_engagement 
diagnosis 
demography 
54 new agents 
36 
disease_progression 
H-positive risk:  888 897 119 906 387 124 924 369 149 49 125 63 
H-negative risk:  897 888 924 906 369 387 124 119 125 149 63 49 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 58 11 

clinical_engagement 
diagnosis 
demography 
71 new agents 
37 
disease_progression 
H-positive risk:  829 832 111 979 390 114 978 366 157 49 133 62 
H-negative risk:  832 829 978 979 366 390 114 111 133 157 62 49 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 60 10 

clinical_engagement 
diagnosis 
demography 
171 new agents 
38 
disease_progression 
H-positive risk:  842 842 117 940 408 115 957 381 148 55 131 64 
H-negative risk:  842 842 957 940 381 408 115 117 131 148 64 55 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 61 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
39 
disease_progression 
H-positive risk:  848 846 116 934 407 117 959 378 149 54 130 62 
H-negative risk:  846 848 959 934 378 407 117 116 130 149 62 54 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 65 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
40 
disease_progression 
H-positive risk:  851 848 116 932 405 113 959 384 147 56 127 62 
H-negative risk:  848 851 959 932 384 405 113 116 127 147 62 56 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 65 7 

clinical_engagement 
diagnosis 
demography 
80 new agents 
41 
disease_progression 
H-positive risk:  853 855 118 943 400 112 954 383 145 52 124 61 
H-negative risk:  855 853 954 943 383 400 112 118 124 145 61 52 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 66 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
42 
disease_progression 
H-positive risk:  852 857 116 944 395 111 952 384 147 55 125 62 
H-negative risk:  857 852 952 944 384 395 111 116 125 147 62 55 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 66 7 

clinical_engagement 
diagnosis 
demography 
62 new agents 
43 
disease_progression 
H-positive risk:  860 864 116 942 388 109 947 382 149 54 128 61 
H-negative risk:  864 860 947 942 382 388 109 116 128 149 61 54 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 65 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
44 
disease_progression 
H-positive risk:  866 861 116 946 385 111 946 384 148 51 127 59 
H-negative risk:  861 866 946 946 384 385 111 116 127 148 59 51 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 68 8 

clinical_engagement 
diagnosis 
demography 
81 new agents 
45 
disease_progression 
H-positive risk:  872 865 117 945 387 111 952 373 144 52 126 56 
H-negative risk:  865 872 952 945 373 387 111 117 126 144 56 52 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 68 7 

clinical_engagement 
diagnosis 
demography 
54 new agents 
46 
disease_progression 
H-positive risk:  874 865 117 951 382 110 953 369 144 50 130 55 
H-negative risk:  865 874 953 951 369 382 110 117 130 144 55 50 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 70 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
47 
disease_progression 
H-positive risk:  881 863 119 959 378 109 949 367 143 51 127 54 
H-negative risk:  863 881 949 959 367 378 109 119 127 143 54 51 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 73 7 

clinical_engagement 
diagnosis 
demography 
35 new agents 
48 
disease_progression 
H-positive risk:  884 856 119 965 374 108 947 368 146 51 128 54 
H-negative risk:  856 884 947 965 368 374 108 119 128 146 54 51 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 73 7 

clinical_engagement 
diagnosis 
demography 
53 new agents 
49 
disease_progression 
H-positive risk:  832 797 113 1025 377 98 1001 365 153 50 136 53 
H-negative risk:  797 832 1001 1025 365 377 98 113 136 153 53 50 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 74 9 

clinical_engagement 
diagnosis 
demography 
145 new agents 
50 
disease_progression 
H-positive risk:  846 802 112 1004 397 101 983 371 149 51 131 53 
H-negative risk:  802 846 983 1004 371 397 101 112 131 149 53 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
91 new agents 
51 
disease_progression 
H-positive risk:  847 810 112 1000 399 101 987 361 148 50 131 54 
H-negative risk:  810 847 987 1000 361 399 101 112 131 148 54 50 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
52 
disease_progression 
H-positive risk:  844 814 112 1001 393 103 988 369 144 52 130 50 
H-negative risk:  814 844 988 1001 369 393 103 112 130 144 50 52 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
53 
disease_progression 
H-positive risk:  850 814 112 999 388 105 984 371 143 53 131 50 
H-negative risk:  814 850 984 999 371 388 105 112 131 143 50 53 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
54 
disease_progression 
H-positive risk:  859 816 112 1002 383 103 978 370 141 54 131 51 
H-negative risk:  816 859 978 1002 370 383 103 112 131 141 51 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
54 new agents 
55 
disease_progression 
H-positive risk:  858 815 112 1011 380 101 976 370 139 56 133 49 
H-negative risk:  815 858 976 1011 370 380 101 112 133 139 49 56 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 75 13 

clinical_engagement 
diagnosis 
demography 
70 new agents 
56 
disease_progression 
H-positive risk:  862 826 111 1010 377 102 974 363 139 55 133 48 
H-negative risk:  826 862 974 1010 363 377 102 111 133 139 48 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 77 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
57 
disease_progression 
H-positive risk:  860 835 111 1007 379 102 974 360 139 54 131 48 
H-negative risk:  835 860 974 1007 360 379 102 111 131 139 48 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 75 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
58 
disease_progression 
H-positive risk:  863 846 111 991 374 102 973 361 139 58 132 50 
H-negative risk:  846 863 973 991 361 374 102 111 132 139 50 58 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 76 13 

clinical_engagement 
diagnosis 
demography 
59 new agents 
59 
disease_progression 
H-positive risk:  861 854 113 985 369 103 974 363 142 58 128 50 
H-negative risk:  854 861 974 985 363 369 103 113 128 142 50 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 78 13 

clinical_engagement 
diagnosis 
demography 
61 new agents 
60 
disease_progression 
H-positive risk:  864 854 114 989 364 102 980 355 144 56 129 49 
H-negative risk:  854 864 980 989 355 364 102 114 129 144 49 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 79 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
61 
disease_progression 
H-positive risk:  807 804 107 1047 360 96 1033 355 147 57 137 50 
H-negative risk:  804 807 1033 1047 355 360 96 107 137 147 50 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 78 13 

clinical_engagement 
diagnosis 
demography 
136 new agents 
62 
disease_progression 
H-positive risk:  809 815 108 1026 375 100 1015 352 145 64 142 49 
H-negative risk:  815 809 1015 1026 352 375 100 108 142 145 49 64 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 75 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
63 
disease_progression 
H-positive risk:  811 813 111 1014 378 102 1014 355 146 62 144 50 
H-negative risk:  813 811 1014 1014 355 378 102 111 144 146 50 62 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 75 11 

clinical_engagement 
diagnosis 
demography 
75 new agents 
64 
disease_progression 
H-positive risk:  812 815 110 1013 373 104 1010 352 149 62 149 51 
H-negative risk:  815 812 1010 1013 352 373 104 110 149 149 51 62 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 75 11 

clinical_engagement 
diagnosis 
demography 
66 new agents 
65 
disease_progression 
H-positive risk:  808 817 111 1009 371 105 1016 351 152 61 149 50 
H-negative risk:  817 808 1016 1009 351 371 105 111 149 152 50 61 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 74 11 

clinical_engagement 
diagnosis 
demography 
64 new agents 
66 
disease_progression 
H-positive risk:  805 818 111 1016 370 108 1014 345 154 62 148 49 
H-negative risk:  818 805 1014 1016 345 370 108 111 148 154 49 62 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 75 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
67 
disease_progression 
H-positive risk:  815 829 109 1005 369 108 1016 340 154 59 143 53 
H-negative risk:  829 815 1016 1005 340 369 108 109 143 154 53 59 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 76 11 

clinical_engagement 
diagnosis 
demography 
64 new agents 
68 
disease_progression 
H-positive risk:  820 831 110 999 375 108 1018 338 152 57 141 51 
H-negative risk:  831 820 1018 999 338 375 108 110 141 152 51 57 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 76 13 

clinical_engagement 
diagnosis 
demography 
85 new agents 
69 
disease_progression 
H-positive risk:  819 834 110 996 370 111 1027 335 151 58 138 51 
H-negative risk:  834 819 1027 996 335 370 111 110 138 151 51 58 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 76 12 

clinical_engagement 
diagnosis 
demography 
73 new agents 
70 
disease_progression 
H-positive risk:  824 834 112 995 369 110 1024 336 149 57 138 52 
H-negative risk:  834 824 1024 995 336 369 110 112 138 149 52 57 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 77 11 

clinical_engagement 
diagnosis 
demography 
64 new agents 
71 
disease_progression 
H-positive risk:  818 834 113 1002 361 111 1017 342 154 57 139 52 
H-negative risk:  834 818 1017 1002 342 361 111 113 139 154 52 57 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 77 10 

clinical_engagement 
diagnosis 
demography 
79 new agents 
72 
disease_progression 
H-positive risk:  818 844 117 993 355 113 1017 340 153 56 141 53 
H-negative risk:  844 818 1017 993 340 355 113 117 141 153 53 56 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 74 10 

clinical_engagement 
diagnosis 
demography 
71 new agents 
73 
disease_progression 
H-positive risk:  772 796 113 1041 353 105 1063 341 164 54 145 53 
H-negative risk:  796 772 1063 1041 341 353 105 113 145 164 53 54 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 76 10 

clinical_engagement 
diagnosis 
demography 
115 new agents 
74 
disease_progression 
H-positive risk:  774 807 115 1018 368 107 1046 357 161 54 141 52 
H-negative risk:  807 774 1046 1018 357 368 107 115 141 161 52 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 79 10 

clinical_engagement 
diagnosis 
demography 
70 new agents 
75 
disease_progression 
H-positive risk:  779 806 115 1024 365 106 1036 362 159 56 142 50 
H-negative risk:  806 779 1036 1024 362 365 106 115 142 159 50 56 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 78 10 

clinical_engagement 
diagnosis 
demography 
74 new agents 
76 
disease_progression 
H-positive risk:  768 809 115 1021 365 107 1049 359 158 56 144 49 
H-negative risk:  809 768 1049 1021 359 365 107 115 144 158 49 56 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 75 10 

clinical_engagement 
diagnosis 
demography 
58 new agents 
77 
disease_progression 
H-positive risk:  773 809 112 1012 368 109 1057 353 153 58 146 50 
H-negative risk:  809 773 1057 1012 353 368 109 112 146 153 50 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 76 11 

clinical_engagement 
diagnosis 
demography 
70 new agents 
78 
disease_progression 
H-positive risk:  774 815 112 1009 370 109 1056 350 154 57 144 50 
H-negative risk:  815 774 1056 1009 350 370 109 112 144 154 50 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 78 12 

clinical_engagement 
diagnosis 
demography 
58 new agents 
79 
disease_progression 
H-positive risk:  764 820 111 1010 369 110 1062 351 153 55 145 50 
H-negative risk:  820 764 1062 1010 351 369 110 111 145 153 50 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 80 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
80 
disease_progression 
H-positive risk:  763 819 111 1022 364 109 1060 345 155 56 146 50 
H-negative risk:  819 763 1060 1022 345 364 109 111 146 155 50 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 81 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
81 
disease_progression 
H-positive risk:  763 815 113 1029 361 108 1066 340 158 55 144 48 
H-negative risk:  815 763 1066 1029 340 361 108 113 144 158 48 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 81 12 

clinical_engagement 
diagnosis 
demography 
66 new agents 
82 
disease_progression 
H-positive risk:  762 818 113 1027 360 106 1070 339 156 55 146 48 
H-negative risk:  818 762 1070 1027 339 360 106 113 146 156 48 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 81 12 

clinical_engagement 
diagnosis 
demography 
70 new agents 
83 
disease_progression 
H-positive risk:  768 814 115 1023 359 105 1069 337 157 56 147 50 
H-negative risk:  814 768 1069 1023 337 359 105 115 147 157 50 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 79 13 

clinical_engagement 
diagnosis 
demography 
70 new agents 
84 
disease_progression 
H-positive risk:  770 814 116 1024 361 104 1064 339 154 58 146 50 
H-negative risk:  814 770 1064 1024 339 361 104 116 146 154 50 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 75 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
85 
disease_progression 
H-positive risk:  724 762 113 1076 362 99 1107 343 159 55 150 50 
H-negative risk:  762 724 1107 1076 343 362 99 113 150 159 50 55 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 75 13 

clinical_engagement 
diagnosis 
demography 
110 new agents 
86 
disease_progression 
H-positive risk:  722 751 112 1070 376 103 1101 354 157 54 148 52 
H-negative risk:  751 722 1101 1070 354 376 103 112 148 157 52 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 75 13 

clinical_engagement 
diagnosis 
demography 
82 new agents 
87 
disease_progression 
H-positive risk:  726 754 111 1070 378 105 1089 359 155 56 146 51 
H-negative risk:  754 726 1089 1070 359 378 105 111 146 155 51 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 76 13 

clinical_engagement 
diagnosis 
demography 
87 new agents 
88 
disease_progression 
H-positive risk:  736 763 106 1058 378 108 1083 363 153 57 144 51 
H-negative risk:  763 736 1083 1058 363 378 108 106 144 153 51 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
89 
disease_progression 
H-positive risk:  737 764 107 1053 380 108 1082 364 153 57 145 50 
H-negative risk:  764 737 1082 1053 364 380 108 107 145 153 50 57 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 71 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
90 
disease_progression 
H-positive risk:  738 770 107 1049 381 110 1072 362 155 58 145 53 
H-negative risk:  770 738 1072 1049 362 381 110 107 145 155 53 58 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
91 
disease_progression 
H-positive risk:  745 775 108 1042 374 114 1071 364 156 55 146 50 
H-negative risk:  775 745 1071 1042 364 374 114 108 146 156 50 55 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 74 13 

clinical_engagement 
diagnosis 
demography 
55 new agents 
92 
disease_progression 
H-positive risk:  744 782 107 1040 379 116 1063 363 155 56 146 49 
H-negative risk:  782 744 1063 1040 363 379 116 107 146 155 49 56 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
93 
disease_progression 
H-positive risk:  742 785 106 1033 379 116 1064 368 156 55 147 49 
H-negative risk:  785 742 1064 1033 368 379 116 106 147 156 49 55 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 75 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
94 
disease_progression 
H-positive risk:  744 794 108 1033 375 115 1048 376 155 52 151 49 
H-negative risk:  794 744 1048 1033 376 375 115 108 151 155 49 52 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 73 12 

clinical_engagement 
diagnosis 
demography 
52 new agents 
95 
disease_progression 
H-positive risk:  742 797 107 1037 376 114 1050 371 155 50 151 50 
H-negative risk:  797 742 1050 1037 371 376 114 107 151 155 50 50 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 76 12 

clinical_engagement 
diagnosis 
demography 
78 new agents 
96 
disease_progression 
H-positive risk:  741 806 108 1032 372 114 1046 380 153 48 152 48 
H-negative risk:  806 741 1046 1032 380 372 114 108 152 153 48 48 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 71 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
97 
disease_progression 
H-positive risk:  705 763 102 1075 378 110 1077 374 160 51 158 47 
H-negative risk:  763 705 1077 1075 374 378 110 102 158 160 47 51 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 71 13 

clinical_engagement 
diagnosis 
demography 
99 new agents 
98 
disease_progression 
H-positive risk:  708 751 102 1061 391 111 1068 391 161 50 157 49 
H-negative risk:  751 708 1068 1061 391 391 111 102 157 161 49 50 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 70 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
99 
disease_progression 
H-positive risk:  703 748 101 1058 395 108 1078 386 163 52 157 51 
H-negative risk:  748 703 1078 1058 386 395 108 101 157 163 51 52 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 66 13 

clinical_engagement 
diagnosis 
demography 
59 new agents 
100 
disease_progression 
H-positive risk:  706 751 101 1054 390 109 1085 386 162 51 151 54 
H-negative risk:  751 706 1085 1054 386 390 109 101 151 162 54 51 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 68 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
101 
disease_progression 
H-positive risk:  703 759 101 1054 390 107 1080 384 160 51 154 57 
H-negative risk:  759 703 1080 1054 384 390 107 101 154 160 57 51 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 68 13 

clinical_engagement 
diagnosis 
demography 
50 new agents 
102 
disease_progression 
H-positive risk:  706 763 102 1052 387 108 1081 381 158 51 152 59 
H-negative risk:  763 706 1081 1052 381 387 108 102 152 158 59 51 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 67 12 

clinical_engagement 
diagnosis 
demography 
82 new agents 
103 
disease_progression 
H-positive risk:  704 761 100 1057 384 106 1087 381 156 55 152 57 
H-negative risk:  761 704 1087 1057 381 384 106 100 152 156 57 55 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 66 12 

clinical_engagement 
diagnosis 
demography 
79 new agents 
104 
disease_progression 
H-positive risk:  716 761 98 1056 374 107 1087 380 158 54 150 59 
H-negative risk:  761 716 1087 1056 380 374 107 98 150 158 59 54 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 64 12 

clinical_engagement 
diagnosis 
demography 
71 new agents 
105 
disease_progression 
H-positive risk:  723 756 98 1049 373 104 1087 384 163 55 150 58 
H-negative risk:  756 723 1087 1049 384 373 104 98 150 163 58 55 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 67 12 

clinical_engagement 
diagnosis 
demography 
85 new agents 
106 
disease_progression 
H-positive risk:  723 759 98 1041 369 104 1086 391 165 55 150 59 
H-negative risk:  759 723 1086 1041 391 369 104 98 150 165 59 55 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 67 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
107 
disease_progression 
H-positive risk:  722 758 99 1040 375 108 1080 388 166 52 155 57 
H-negative risk:  758 722 1080 1040 388 375 108 99 155 166 57 52 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
108 
disease_progression 
H-positive risk:  717 764 97 1033 380 111 1089 387 161 54 154 53 
H-negative risk:  764 717 1089 1033 387 380 111 97 154 161 53 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
58 new agents 
109 
disease_progression 
H-positive risk:  672 727 95 1062 382 105 1133 387 171 55 161 50 
H-negative risk:  727 672 1133 1062 387 382 105 95 161 171 50 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
100 new agents 
110 
disease_progression 
H-positive risk:  671 737 94 1054 384 99 1115 405 173 61 157 50 
H-negative risk:  737 671 1115 1054 405 384 99 94 157 173 50 61 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
89 new agents 
111 
disease_progression 
H-positive risk:  677 742 91 1046 387 101 1107 412 168 62 160 47 
H-negative risk:  742 677 1107 1046 412 387 101 91 160 168 47 62 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
112 
disease_progression 
H-positive risk:  685 743 90 1042 380 103 1111 411 165 63 160 47 
H-negative risk:  743 685 1111 1042 411 380 103 90 160 165 47 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
113 
disease_progression 
H-positive risk:  690 734 89 1048 381 102 1115 407 163 63 160 48 
H-negative risk:  734 690 1115 1048 407 381 102 89 160 163 48 63 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
114 
disease_progression 
H-positive risk:  689 736 91 1047 385 101 1112 407 161 62 159 50 
H-negative risk:  736 689 1112 1047 407 385 101 91 159 161 50 62 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
115 
disease_progression 
H-positive risk:  691 731 93 1059 378 101 1106 411 161 61 160 48 
H-negative risk:  731 691 1106 1059 411 378 101 93 160 161 48 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
116 
disease_progression 
H-positive risk:  687 732 95 1064 375 100 1108 413 163 57 157 49 
H-negative risk:  732 687 1108 1064 413 375 100 95 157 163 49 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
117 
disease_progression 
H-positive risk:  684 736 94 1062 371 97 1113 419 161 60 155 48 
H-negative risk:  736 684 1113 1062 419 371 97 94 155 161 48 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
118 
disease_progression 
H-positive risk:  676 737 93 1070 370 96 1116 417 163 58 156 48 
H-negative risk:  737 676 1116 1070 417 370 96 93 156 163 48 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
119 
disease_progression 
H-positive risk:  672 737 92 1071 373 97 1109 421 163 59 156 50 
H-negative risk:  737 672 1109 1071 421 373 97 92 156 163 50 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
120 
disease_progression 
H-positive risk:  670 738 91 1073 373 96 1109 421 159 63 156 51 
H-negative risk:  738 670 1109 1073 421 373 96 91 156 159 51 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
121 
disease_progression 
H-positive risk:  629 708 88 1103 370 88 1150 421 162 66 161 54 
H-negative risk:  708 629 1150 1103 421 370 88 88 161 162 54 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
118 new agents 
122 
disease_progression 
H-positive risk:  628 710 86 1099 381 88 1148 416 165 61 157 61 
H-negative risk:  710 628 1148 1099 416 381 88 86 157 165 61 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
123 
disease_progression 
H-positive risk:  628 711 85 1100 379 88 1144 422 162 64 155 62 
H-negative risk:  711 628 1144 1100 422 379 88 85 155 162 62 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
124 
disease_progression 
H-positive risk:  635 708 83 1096 387 87 1144 415 163 64 157 61 
H-negative risk:  708 635 1144 1096 415 387 87 83 157 163 61 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
125 
disease_progression 
H-positive risk:  639 709 82 1103 379 86 1141 420 163 64 154 60 
H-negative risk:  709 639 1141 1103 420 379 86 82 154 163 60 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
126 
disease_progression 
H-positive risk:  644 709 85 1112 372 88 1140 414 160 62 155 59 
H-negative risk:  709 644 1140 1112 414 372 88 85 155 160 59 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
127 
disease_progression 
H-positive risk:  647 705 84 1113 375 88 1134 418 160 63 151 62 
H-negative risk:  705 647 1134 1113 418 375 88 84 151 160 62 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
128 
disease_progression 
H-positive risk:  638 708 85 1115 374 90 1138 419 160 62 153 58 
H-negative risk:  708 638 1138 1115 419 374 90 85 153 160 58 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
129 
disease_progression 
H-positive risk:  644 709 88 1116 365 92 1135 418 163 62 151 57 
H-negative risk:  709 644 1135 1116 418 365 92 88 151 163 57 62 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
130 
disease_progression 
H-positive risk:  646 707 87 1123 367 95 1137 415 157 64 146 56 
H-negative risk:  707 646 1137 1123 415 367 95 87 146 157 56 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
131 
disease_progression 
H-positive risk:  643 707 89 1115 370 97 1141 417 158 64 146 53 
H-negative risk:  707 643 1141 1115 417 370 97 89 146 158 53 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
132 
disease_progression 
H-positive risk:  645 710 89 1116 366 96 1142 408 160 66 149 53 
H-negative risk:  710 645 1142 1116 408 366 96 89 149 160 53 66 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
133 
disease_progression 
H-positive risk:  639 712 89 1116 362 96 1148 403 164 66 152 53 
H-negative risk:  712 639 1148 1116 403 362 96 89 152 164 53 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
134 
disease_progression 
H-positive risk:  636 712 90 1108 376 95 1134 414 166 67 153 49 
H-negative risk:  712 636 1134 1108 414 376 95 90 153 166 49 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
135 
disease_progression 
H-positive risk:  635 712 91 1102 380 97 1134 414 166 69 150 50 
H-negative risk:  712 635 1134 1102 414 380 97 91 150 166 50 69 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
136 
disease_progression 
H-positive risk:  638 705 93 1100 381 97 1133 415 167 70 147 54 
H-negative risk:  705 638 1133 1100 415 381 97 93 147 167 54 70 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
58 new agents 
137 
disease_progression 
H-positive risk:  635 702 90 1109 376 98 1130 419 167 71 149 54 
H-negative risk:  702 635 1130 1109 419 376 98 90 149 167 54 71 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
138 
disease_progression 
H-positive risk:  634 701 92 1106 378 99 1124 422 165 71 151 57 
H-negative risk:  701 634 1124 1106 422 378 99 92 151 165 57 71 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
139 
disease_progression 
H-positive risk:  628 689 92 1111 378 96 1131 425 169 70 155 56 
H-negative risk:  689 628 1131 1111 425 378 96 92 155 169 56 70 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
140 
disease_progression 
H-positive risk:  628 687 91 1102 383 96 1139 425 169 66 157 57 
H-negative risk:  687 628 1139 1102 425 383 96 91 157 169 57 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
141 
disease_progression 
H-positive risk:  620 680 94 1100 384 95 1156 423 171 66 153 58 
H-negative risk:  680 620 1156 1100 423 384 95 94 153 171 58 66 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
142 
disease_progression 
H-positive risk:  620 678 92 1103 377 95 1162 427 171 65 155 55 
H-negative risk:  678 620 1162 1103 427 377 95 92 155 171 55 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
143 
disease_progression 
H-positive risk:  621 680 91 1099 383 95 1159 423 168 65 160 56 
H-negative risk:  680 621 1159 1099 423 383 95 91 160 168 56 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
144 
disease_progression 
H-positive risk:  622 676 95 1101 380 94 1156 425 173 62 159 57 
H-negative risk:  676 622 1156 1101 425 380 94 95 159 173 57 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
145 
disease_progression 
H-positive risk:  627 673 97 1107 375 93 1151 421 180 60 159 57 
H-negative risk:  673 627 1151 1107 421 375 93 97 159 180 57 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
146 
disease_progression 
H-positive risk:  623 670 97 1100 394 96 1128 437 181 58 159 57 
H-negative risk:  670 623 1128 1100 437 394 96 97 159 181 57 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
147 
disease_progression 
H-positive risk:  623 669 99 1101 389 94 1135 437 176 63 156 58 
H-negative risk:  669 623 1135 1101 437 389 94 99 156 176 58 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
148 
disease_progression 
H-positive risk:  628 670 102 1099 387 91 1139 431 179 62 154 58 
H-negative risk:  670 628 1139 1099 431 387 91 102 154 179 58 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
149 
disease_progression 
H-positive risk:  634 673 99 1107 379 93 1133 432 181 61 152 56 
H-negative risk:  673 634 1133 1107 432 379 93 99 152 181 56 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
90 new agents 
150 
disease_progression 
H-positive risk:  646 675 99 1114 361 94 1134 429 183 58 151 56 
H-negative risk:  675 646 1134 1114 429 361 94 99 151 183 56 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
151 
disease_progression 
H-positive risk:  643 677 98 1122 360 92 1137 422 182 59 151 57 
H-negative risk:  677 643 1137 1122 422 360 92 98 151 182 57 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
152 
disease_progression 
H-positive risk:  645 676 98 1120 361 92 1139 416 183 59 152 59 
H-negative risk:  676 645 1139 1120 416 361 92 98 152 183 59 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
153 
disease_progression 
H-positive risk:  645 674 98 1125 364 93 1141 408 181 60 153 58 
H-negative risk:  674 645 1141 1125 408 364 93 98 153 181 58 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
154 
disease_progression 
H-positive risk:  648 671 97 1128 365 95 1142 403 181 60 152 58 
H-negative risk:  671 648 1142 1128 403 365 95 97 152 181 58 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
155 
disease_progression 
H-positive risk:  656 673 97 1121 362 95 1134 408 181 59 153 61 
H-negative risk:  673 656 1134 1121 408 362 95 97 153 181 61 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
156 
disease_progression 
H-positive risk:  661 679 96 1119 364 99 1123 406 179 58 155 61 
H-negative risk:  679 661 1123 1119 406 364 99 96 155 179 61 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
157 
disease_progression 
H-positive risk:  666 685 97 1113 361 99 1120 404 179 57 157 62 
H-negative risk:  685 666 1120 1113 404 361 99 97 157 179 62 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
158 
disease_progression 
H-positive risk:  665 682 96 1100 370 96 1112 420 182 58 157 62 
H-negative risk:  682 665 1112 1100 420 370 96 96 157 182 62 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
159 
disease_progression 
H-positive risk:  671 685 96 1090 368 97 1113 422 184 57 153 64 
H-negative risk:  685 671 1113 1090 422 368 97 96 153 184 64 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
160 
disease_progression 
H-positive risk:  674 693 97 1088 369 99 1101 420 184 56 155 64 
H-negative risk:  693 674 1101 1088 420 369 99 97 155 184 64 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
161 
disease_progression 
H-positive risk:  664 684 100 1089 374 97 1113 422 183 56 156 62 
H-negative risk:  684 664 1113 1089 422 374 97 100 156 183 62 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
162 
disease_progression 
H-positive risk:  658 685 100 1094 377 99 1110 421 181 56 158 61 
H-negative risk:  685 658 1110 1094 421 377 99 100 158 181 61 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
163 
disease_progression 
H-positive risk:  652 689 98 1091 377 101 1118 422 179 57 155 61 
H-negative risk:  689 652 1118 1091 422 377 101 98 155 179 61 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
164 
disease_progression 
H-positive risk:  653 694 97 1090 374 102 1119 421 180 55 157 58 
H-negative risk:  694 653 1119 1090 421 374 102 97 157 180 58 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
165 
disease_progression 
H-positive risk:  656 689 96 1096 376 99 1122 414 181 57 155 59 
H-negative risk:  689 656 1122 1096 414 376 99 96 155 181 59 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
166 
disease_progression 
H-positive risk:  664 692 95 1098 376 100 1107 419 180 56 158 55 
H-negative risk:  692 664 1107 1098 419 376 100 95 158 180 55 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
167 
disease_progression 
H-positive risk:  663 700 98 1091 369 100 1109 416 184 57 161 52 
H-negative risk:  700 663 1109 1091 416 369 100 98 161 184 52 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
168 
disease_progression 
H-positive risk:  664 697 95 1088 371 100 1109 418 184 56 166 52 
H-negative risk:  697 664 1109 1088 418 371 100 95 166 184 52 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
169 
disease_progression 
H-positive risk:  664 695 95 1094 370 102 1107 416 181 59 165 52 
H-negative risk:  695 664 1107 1094 416 370 102 95 165 181 52 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
170 
disease_progression 
H-positive risk:  665 693 92 1089 382 103 1115 408 180 58 167 48 
H-negative risk:  693 665 1115 1089 408 382 103 92 167 180 48 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
171 
disease_progression 
H-positive risk:  663 690 90 1086 385 105 1132 403 179 53 165 49 
H-negative risk:  690 663 1132 1086 403 385 105 90 165 179 49 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
172 
disease_progression 
H-positive risk:  658 687 89 1093 384 105 1130 400 181 54 168 51 
H-negative risk:  687 658 1130 1093 400 384 105 89 168 181 51 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
173 
disease_progression 
H-positive risk:  660 691 91 1096 384 105 1125 393 183 54 165 53 
H-negative risk:  691 660 1125 1096 393 384 105 91 165 183 53 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
57 new agents 
174 
disease_progression 
H-positive risk:  657 686 92 1112 378 105 1133 381 186 53 164 53 
H-negative risk:  686 657 1133 1112 381 378 105 92 164 186 53 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
175 
disease_progression 
H-positive risk:  664 684 92 1112 381 105 1128 387 183 55 159 50 
H-negative risk:  684 664 1128 1112 387 381 105 92 159 183 50 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
176 
disease_progression 
H-positive risk:  670 683 93 1123 375 104 1122 385 184 55 158 48 
H-negative risk:  683 670 1122 1123 385 375 104 93 158 184 48 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
177 
disease_progression 
H-positive risk:  666 686 95 1122 376 104 1123 386 184 51 159 48 
H-negative risk:  686 666 1123 1122 386 376 104 95 159 184 48 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
178 
disease_progression 
H-positive risk:  668 695 96 1120 378 104 1114 386 181 50 161 47 
H-negative risk:  695 668 1114 1120 386 378 104 96 161 181 47 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
179 
disease_progression 
H-positive risk:  667 695 94 1114 384 104 1115 384 183 50 163 47 
H-negative risk:  695 667 1115 1114 384 384 104 94 163 183 47 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
180 
disease_progression 
H-positive risk:  661 699 94 1122 385 102 1118 374 189 49 161 46 
H-negative risk:  699 661 1118 1122 374 385 102 94 161 189 46 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
181 
disease_progression 
H-positive risk:  664 703 92 1120 389 102 1111 369 192 47 163 48 
H-negative risk:  703 664 1111 1120 369 389 102 92 163 192 48 47 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
182 
disease_progression 
H-positive risk:  656 695 92 1117 395 101 1120 373 192 46 163 50 
H-negative risk:  695 656 1120 1117 373 395 101 92 163 192 50 46 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
183 
disease_progression 
H-positive risk:  650 697 96 1122 387 102 1110 384 195 45 160 52 
H-negative risk:  697 650 1110 1122 384 387 102 96 160 195 52 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
184 
disease_progression 
H-positive risk:  650 689 96 1121 390 102 1113 388 194 44 161 52 
H-negative risk:  689 650 1113 1121 388 390 102 96 161 194 52 44 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
185 
disease_progression 
H-positive risk:  653 691 95 1116 386 102 1119 383 192 47 163 53 
H-negative risk:  691 653 1119 1116 383 386 102 95 163 192 53 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
186 
disease_progression 
H-positive risk:  663 686 94 1119 385 106 1115 376 190 47 166 53 
H-negative risk:  686 663 1115 1119 376 385 106 94 166 190 53 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
187 
disease_progression 
H-positive risk:  660 685 95 1121 383 105 1122 375 192 46 166 50 
H-negative risk:  685 660 1122 1121 375 383 105 95 166 192 50 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
188 
disease_progression 
H-positive risk:  655 690 94 1120 383 109 1121 376 193 45 164 50 
H-negative risk:  690 655 1121 1120 376 383 109 94 164 193 50 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
189 
disease_progression 
H-positive risk:  649 694 96 1119 381 109 1124 378 191 45 165 49 
H-negative risk:  694 649 1124 1119 378 381 109 96 165 191 49 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
190 
disease_progression 
H-positive risk:  652 684 96 1120 384 109 1119 384 191 45 166 50 
H-negative risk:  684 652 1119 1120 384 384 109 96 166 191 50 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
191 
disease_progression 
H-positive risk:  648 684 95 1118 380 111 1126 386 191 44 164 53 
H-negative risk:  684 648 1126 1118 386 380 111 95 164 191 53 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
192 
disease_progression 
H-positive risk:  646 684 97 1125 378 110 1122 385 188 50 162 53 
H-negative risk:  684 646 1122 1125 385 378 110 97 162 188 53 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
193 
disease_progression 
H-positive risk:  639 682 93 1133 384 111 1122 383 185 49 165 54 
H-negative risk:  682 639 1122 1133 383 384 111 93 165 185 54 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
194 
disease_progression 
H-positive risk:  643 683 98 1134 386 113 1111 380 183 50 164 55 
H-negative risk:  683 643 1111 1134 380 386 113 98 164 183 55 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
195 
disease_progression 
H-positive risk:  640 678 99 1128 390 112 1113 383 184 50 163 60 
H-negative risk:  678 640 1113 1128 383 390 112 99 163 184 60 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
196 
disease_progression 
H-positive risk:  638 679 100 1133 389 117 1117 375 182 51 160 59 
H-negative risk:  679 638 1117 1133 375 389 117 100 160 182 59 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
197 
disease_progression 
H-positive risk:  640 679 101 1134 387 118 1114 376 179 51 165 56 
H-negative risk:  679 640 1114 1134 376 387 118 101 165 179 56 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
198 
disease_progression 
H-positive risk:  630 675 102 1136 384 116 1122 383 179 52 164 57 
H-negative risk:  675 630 1122 1136 383 384 116 102 164 179 57 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
199 
disease_progression 
H-positive risk:  632 680 102 1133 386 116 1116 388 176 52 161 58 
H-negative risk:  680 632 1116 1133 388 386 116 102 161 176 58 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
200 
disease_progression 
H-positive risk:  635 680 103 1141 398 115 1102 385 171 51 160 59 
H-negative risk:  680 635 1102 1141 385 398 115 103 160 171 59 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
201 
disease_progression 
H-positive risk:  626 679 104 1147 388 116 1108 392 170 52 161 57 
H-negative risk:  679 626 1108 1147 392 388 116 104 161 170 57 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
57 new agents 
202 
disease_progression 
H-positive risk:  621 668 104 1149 391 116 1115 393 169 54 164 56 
H-negative risk:  668 621 1115 1149 393 391 116 104 164 169 56 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
203 
disease_progression 
H-positive risk:  618 671 103 1148 390 118 1123 382 171 55 166 55 
H-negative risk:  671 618 1123 1148 382 390 118 103 166 171 55 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
204 
disease_progression 
H-positive risk:  628 667 103 1147 390 112 1116 380 178 55 168 56 
H-negative risk:  667 628 1116 1147 380 390 112 103 168 178 56 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
205 
disease_progression 
H-positive risk:  633 660 105 1148 392 110 1118 378 175 59 166 56 
H-negative risk:  660 633 1118 1148 378 392 110 105 166 175 56 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
206 
disease_progression 
H-positive risk:  634 658 104 1147 396 108 1107 390 172 63 164 57 
H-negative risk:  658 634 1107 1147 390 396 108 104 164 172 57 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
207 
disease_progression 
H-positive risk:  627 665 104 1148 393 106 1105 397 176 60 160 59 
H-negative risk:  665 627 1105 1148 397 393 106 104 160 176 59 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
208 
disease_progression 
H-positive risk:  632 663 101 1149 394 104 1108 401 172 59 161 56 
H-negative risk:  663 632 1108 1149 401 394 104 101 161 172 56 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
209 
disease_progression 
H-positive risk:  638 669 102 1142 390 105 1106 400 168 62 162 56 
H-negative risk:  669 638 1106 1142 400 390 105 102 162 168 56 62 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
58 new agents 
210 
disease_progression 
H-positive risk:  633 672 101 1145 385 107 1100 404 171 62 163 57 
H-negative risk:  672 633 1100 1145 404 385 107 101 163 171 57 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
53 new agents 
211 
disease_progression 
H-positive risk:  636 675 102 1146 381 105 1094 406 173 62 164 56 
H-negative risk:  675 636 1094 1146 406 381 105 102 164 173 56 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
212 
disease_progression 
H-positive risk:  636 685 103 1138 366 105 1101 409 174 61 166 56 
H-negative risk:  685 636 1101 1138 409 366 105 103 166 174 56 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
213 
disease_progression 
H-positive risk:  636 679 100 1138 363 104 1109 408 179 62 168 54 
H-negative risk:  679 636 1109 1138 408 363 104 100 168 179 54 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
214 
disease_progression 
H-positive risk:  627 684 99 1135 370 108 1114 397 180 63 169 54 
H-negative risk:  684 627 1114 1135 397 370 108 99 169 180 54 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
215 
disease_progression 
H-positive risk:  634 683 101 1138 367 106 1108 396 182 64 169 52 
H-negative risk:  683 634 1108 1138 396 367 106 101 169 182 52 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
216 
disease_progression 
H-positive risk:  631 681 100 1137 373 107 1110 394 182 63 169 53 
H-negative risk:  681 631 1110 1137 394 373 107 100 169 182 53 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
217 
disease_progression 
H-positive risk:  632 690 101 1120 378 104 1098 410 179 64 167 57 
H-negative risk:  690 632 1098 1120 410 378 104 101 167 179 57 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
218 
disease_progression 
H-positive risk:  634 689 104 1119 380 105 1097 408 178 64 168 54 
H-negative risk:  689 634 1097 1119 408 380 105 104 168 178 54 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
100 new agents 
219 
disease_progression 
H-positive risk:  643 686 103 1126 367 105 1095 411 179 66 168 51 
H-negative risk:  686 643 1095 1126 411 367 105 103 168 179 51 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
220 
disease_progression 
H-positive risk:  634 683 99 1122 373 107 1102 413 182 68 168 49 
H-negative risk:  683 634 1102 1122 413 373 107 99 168 182 49 68 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
221 
disease_progression 
H-positive risk:  635 679 98 1123 374 107 1100 415 182 67 170 50 
H-negative risk:  679 635 1100 1123 415 374 107 98 170 182 50 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
222 
disease_progression 
H-positive risk:  643 685 98 1118 381 104 1084 419 181 65 169 53 
H-negative risk:  685 643 1084 1118 419 381 104 98 169 181 53 65 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
223 
disease_progression 
H-positive risk:  647 680 99 1116 389 104 1083 419 179 64 169 51 
H-negative risk:  680 647 1083 1116 419 389 104 99 169 179 51 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
224 
disease_progression 
H-positive risk:  654 677 99 1123 390 104 1076 417 179 63 165 53 
H-negative risk:  677 654 1076 1123 417 390 104 99 165 179 53 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
225 
disease_progression 
H-positive risk:  655 676 98 1113 391 105 1086 414 178 63 167 54 
H-negative risk:  676 655 1086 1113 414 391 105 98 167 178 54 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
226 
disease_progression 
H-positive risk:  651 671 98 1110 392 105 1087 420 180 63 171 52 
H-negative risk:  671 651 1087 1110 420 392 105 98 171 180 52 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
227 
disease_progression 
H-positive risk:  653 670 97 1103 402 105 1090 417 181 62 170 50 
H-negative risk:  670 653 1090 1103 417 402 105 97 170 181 50 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
228 
disease_progression 
H-positive risk:  657 668 100 1111 397 104 1089 417 180 62 168 47 
H-negative risk:  668 657 1089 1111 417 397 104 100 168 180 47 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
229 
disease_progression 
H-positive risk:  659 665 97 1110 404 105 1083 421 177 64 166 49 
H-negative risk:  665 659 1083 1110 421 404 105 97 166 177 49 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
230 
disease_progression 
H-positive risk:  651 661 94 1121 404 102 1090 419 181 65 163 49 
H-negative risk:  661 651 1090 1121 419 404 102 94 163 181 49 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
92 new agents 
231 
disease_progression 
H-positive risk:  651 666 95 1116 408 97 1081 421 185 68 163 49 
H-negative risk:  666 651 1081 1116 421 408 97 95 163 185 49 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
232 
disease_progression 
H-positive risk:  648 672 96 1115 407 99 1080 421 187 65 160 50 
H-negative risk:  672 648 1080 1115 421 407 99 96 160 187 50 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
233 
disease_progression 
H-positive risk:  645 676 94 1121 405 98 1077 419 187 65 163 50 
H-negative risk:  676 645 1077 1121 419 405 98 94 163 187 50 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
234 
disease_progression 
H-positive risk:  644 678 93 1114 410 98 1093 410 186 65 159 50 
H-negative risk:  678 644 1093 1114 410 410 98 93 159 186 50 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
235 
disease_progression 
H-positive risk:  643 680 97 1112 412 95 1092 414 187 61 159 48 
H-negative risk:  680 643 1092 1112 414 412 95 97 159 187 48 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
236 
disease_progression 
H-positive risk:  645 680 99 1109 406 91 1096 418 189 61 158 48 
H-negative risk:  680 645 1096 1109 418 406 91 99 158 189 48 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
237 
disease_progression 
H-positive risk:  643 677 100 1104 407 91 1103 417 188 62 159 49 
H-negative risk:  677 643 1103 1104 417 407 91 100 159 188 49 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
238 
disease_progression 
H-positive risk:  646 676 100 1100 407 92 1106 420 185 60 157 51 
H-negative risk:  676 646 1106 1100 420 407 92 100 157 185 51 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
239 
disease_progression 
H-positive risk:  653 678 98 1105 404 92 1096 420 185 61 157 51 
H-negative risk:  678 653 1096 1105 420 404 92 98 157 185 51 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
240 
disease_progression 
H-positive risk:  654 673 94 1101 408 92 1102 423 180 63 160 50 
H-negative risk:  673 654 1102 1101 423 408 92 94 160 180 50 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  658 670 95 1084 421 92 1097 432 179 63 155 54 
H-negative risk:  670 658 1097 1084 432 421 92 95 155 179 54 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
242 
disease_progression 
H-positive risk:  660 671 97 1082 418 98 1103 430 174 61 155 51 
H-negative risk:  671 660 1103 1082 430 418 98 97 155 174 51 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
243 
disease_progression 
H-positive risk:  654 665 94 1088 416 99 1112 429 176 61 157 49 
H-negative risk:  665 654 1112 1088 429 416 99 94 157 176 49 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
244 
disease_progression 
H-positive risk:  654 662 95 1087 418 99 1111 434 176 61 156 47 
H-negative risk:  662 654 1111 1087 434 418 99 95 156 176 47 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
245 
disease_progression 
H-positive risk:  645 655 97 1088 419 97 1120 439 174 62 158 46 
H-negative risk:  655 645 1120 1088 439 419 97 97 158 174 46 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
246 
disease_progression 
H-positive risk:  649 657 95 1089 420 99 1105 443 172 61 162 48 
H-negative risk:  657 649 1105 1089 443 420 99 95 162 172 48 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
247 
disease_progression 
H-positive risk:  650 653 95 1092 419 99 1112 442 169 61 159 49 
H-negative risk:  653 650 1112 1092 442 419 99 95 159 169 49 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
248 
disease_progression 
H-positive risk:  650 654 95 1092 419 99 1112 437 171 62 157 52 
H-negative risk:  654 650 1112 1092 437 419 99 95 157 171 52 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
249 
disease_progression 
H-positive risk:  654 657 93 1097 425 97 1104 430 172 62 154 55 
H-negative risk:  657 654 1104 1097 430 425 97 93 154 172 55 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
250 
disease_progression 
H-positive risk:  651 652 94 1107 425 97 1113 422 174 61 152 52 
H-negative risk:  652 651 1113 1107 422 425 97 94 152 174 52 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
251 
disease_progression 
H-positive risk:  657 658 94 1106 422 95 1103 423 169 62 157 54 
H-negative risk:  658 657 1103 1106 423 422 95 94 157 169 54 62 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 89 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
252 
disease_progression 
H-positive risk:  657 656 95 1106 423 94 1108 425 168 63 152 53 
H-negative risk:  656 657 1108 1106 425 423 94 95 152 168 53 63 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 88 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
253 
disease_progression 
H-positive risk:  649 664 94 1098 424 95 1109 428 167 65 155 52 
H-negative risk:  664 649 1109 1098 428 424 95 94 155 167 52 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 85 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
254 
disease_progression 
H-positive risk:  651 662 92 1104 419 98 1106 425 168 65 158 52 
H-negative risk:  662 651 1106 1104 425 419 98 92 158 168 52 65 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 89 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
255 
disease_progression 
H-positive risk:  650 669 93 1103 416 97 1107 424 168 63 159 51 
H-negative risk:  669 650 1107 1103 424 416 97 93 159 168 51 63 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
256 
disease_progression 
H-positive risk:  643 676 91 1100 419 98 1102 432 167 62 160 50 
H-negative risk:  676 643 1102 1100 432 419 98 91 160 167 50 62 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 89 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
257 
disease_progression 
H-positive risk:  642 674 90 1100 424 97 1098 437 165 64 161 48 
H-negative risk:  674 642 1098 1100 437 424 97 90 161 165 48 64 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 90 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
258 
disease_progression 
H-positive risk:  645 672 89 1102 428 95 1099 436 165 61 160 48 
H-negative risk:  672 645 1099 1102 436 428 95 89 160 165 48 61 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 90 36 

clinical_engagement 
diagnosis 
demography 
74 new agents 
259 
disease_progression 
H-positive risk:  643 674 89 1103 426 99 1098 436 166 58 159 49 
H-negative risk:  674 643 1098 1103 436 426 99 89 159 166 49 58 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 92 38 

clinical_engagement 
diagnosis 
demography 
78 new agents 
260 
disease_progression 
H-positive risk:  646 667 90 1103 434 99 1098 431 167 60 156 49 
H-negative risk:  667 646 1098 1103 431 434 99 90 156 167 49 60 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 90 38 

clinical_engagement 
diagnosis 
demography 
65 new agents 
261 
disease_progression 
H-positive risk:  653 667 91 1104 431 100 1096 429 165 61 151 52 
H-negative risk:  667 653 1096 1104 429 431 100 91 151 165 52 61 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 90 37 

clinical_engagement 
diagnosis 
demography 
64 new agents 
262 
disease_progression 
H-positive risk:  654 661 92 1108 431 100 1091 432 165 60 152 54 
H-negative risk:  661 654 1091 1108 432 431 100 92 152 165 54 60 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 89 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
263 
disease_progression 
H-positive risk:  647 665 93 1109 433 99 1091 433 165 62 147 56 
H-negative risk:  665 647 1091 1109 433 433 99 93 147 165 56 62 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 87 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
264 
disease_progression 
H-positive risk:  651 667 96 1103 439 99 1090 425 164 62 147 57 
H-negative risk:  667 651 1090 1103 425 439 99 96 147 164 57 62 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 88 36 

clinical_engagement 
diagnosis 
demography 
77 new agents 
265 
disease_progression 
H-positive risk:  653 672 95 1107 433 100 1082 422 166 67 147 56 
H-negative risk:  672 653 1082 1107 422 433 100 95 147 166 56 67 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 89 36 

clinical_engagement 
diagnosis 
demography 
97 new agents 
266 
disease_progression 
H-positive risk:  665 675 92 1106 427 98 1092 413 164 65 145 58 
H-negative risk:  675 665 1092 1106 413 427 98 92 145 164 58 65 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 90 36 

clinical_engagement 
diagnosis 
demography 
91 new agents 
267 
disease_progression 
H-positive risk:  667 680 95 1104 421 98 1099 409 163 63 144 57 
H-negative risk:  680 667 1099 1104 409 421 98 95 144 163 57 63 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 87 35 

clinical_engagement 
diagnosis 
demography 
80 new agents 
268 
disease_progression 
H-positive risk:  662 680 94 1102 426 96 1101 407 163 68 142 59 
H-negative risk:  680 662 1101 1102 407 426 96 94 142 163 59 68 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 86 39 

clinical_engagement 
diagnosis 
demography 
82 new agents 
269 
disease_progression 
H-positive risk:  665 679 94 1107 426 95 1103 404 161 66 145 55 
H-negative risk:  679 665 1103 1107 404 426 95 94 145 161 55 66 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 86 37 

clinical_engagement 
diagnosis 
demography 
89 new agents 
270 
disease_progression 
H-positive risk:  667 683 93 1106 430 97 1095 398 160 70 143 58 
H-negative risk:  683 667 1095 1106 398 430 97 93 143 160 58 70 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 87 37 

clinical_engagement 
diagnosis 
demography 
75 new agents 
271 
disease_progression 
H-positive risk:  668 685 92 1103 424 97 1099 401 158 70 146 57 
H-negative risk:  685 668 1099 1103 401 424 97 92 146 158 57 70 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 87 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
272 
disease_progression 
H-positive risk:  660 689 91 1099 434 97 1100 399 157 71 145 58 
H-negative risk:  689 660 1100 1099 399 434 97 91 145 157 58 71 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 89 39 

clinical_engagement 
diagnosis 
demography 
75 new agents 
273 
disease_progression 
H-positive risk:  663 694 91 1101 424 98 1096 403 157 69 144 60 
H-negative risk:  694 663 1096 1101 403 424 98 91 144 157 60 69 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 90 37 

clinical_engagement 
diagnosis 
demography 
63 new agents 
274 
disease_progression 
H-positive risk:  664 706 87 1099 414 99 1095 408 151 74 144 59 
H-negative risk:  706 664 1095 1099 408 414 99 87 144 151 59 74 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 88 37 

clinical_engagement 
diagnosis 
demography 
66 new agents 
275 
disease_progression 
H-positive risk:  669 688 85 1099 426 101 1084 413 153 74 147 61 
H-negative risk:  688 669 1084 1099 413 426 101 85 147 153 61 74 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 86 36 

clinical_engagement 
diagnosis 
demography 
70 new agents 
276 
disease_progression 
H-positive risk:  671 691 82 1107 424 100 1081 412 152 73 145 62 
H-negative risk:  691 671 1081 1107 412 424 100 82 145 152 62 73 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 85 36 

clinical_engagement 
diagnosis 
demography 
71 new agents 
277 
disease_progression 
H-positive risk:  671 689 82 1110 427 99 1081 414 152 71 144 60 
H-negative risk:  689 671 1081 1110 414 427 99 82 144 152 60 71 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 87 35 

clinical_engagement 
diagnosis 
demography 
79 new agents 
278 
disease_progression 
H-positive risk:  663 697 81 1102 426 103 1081 416 152 69 148 62 
H-negative risk:  697 663 1081 1102 416 426 103 81 148 152 62 69 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 88 35 

clinical_engagement 
diagnosis 
demography 
83 new agents 
279 
disease_progression 
H-positive risk:  669 702 80 1103 428 102 1076 410 152 66 147 65 
H-negative risk:  702 669 1076 1103 410 428 102 80 147 152 65 66 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 88 35 

clinical_engagement 
diagnosis 
demography 
84 new agents 
280 
disease_progression 
H-positive risk:  667 705 80 1109 433 101 1065 420 147 65 145 63 
H-negative risk:  705 667 1065 1109 420 433 101 80 145 147 63 65 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 90 37 

clinical_engagement 
diagnosis 
demography 
65 new agents 
281 
disease_progression 
H-positive risk:  669 714 78 1107 436 100 1060 419 144 68 142 63 
H-negative risk:  714 669 1060 1107 419 436 100 78 142 144 63 68 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 89 37 

clinical_engagement 
diagnosis 
demography 
79 new agents 
282 
disease_progression 
H-positive risk:  672 717 79 1112 439 102 1050 412 141 70 142 64 
H-negative risk:  717 672 1050 1112 412 439 102 79 142 141 64 70 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 88 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
283 
disease_progression 
H-positive risk:  670 721 79 1097 443 101 1054 412 144 71 142 66 
H-negative risk:  721 670 1054 1097 412 443 101 79 142 144 66 71 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 90 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
284 
disease_progression 
H-positive risk:  669 715 76 1100 449 98 1059 411 145 73 139 66 
H-negative risk:  715 669 1059 1100 411 449 98 76 139 145 66 73 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 89 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
285 
disease_progression 
H-positive risk:  669 720 75 1094 440 99 1060 419 146 72 140 66 
H-negative risk:  720 669 1060 1094 419 440 99 75 140 146 66 72 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 93 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
286 
disease_progression 
H-positive risk:  671 719 72 1089 448 99 1063 411 148 68 145 67 
H-negative risk:  719 671 1063 1089 411 448 99 72 145 148 67 68 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
287 
disease_progression 
H-positive risk:  661 710 74 1087 451 102 1072 408 155 69 144 67 
H-negative risk:  710 661 1072 1087 408 451 102 74 144 155 67 69 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
288 
disease_progression 
H-positive risk:  662 713 72 1082 449 103 1078 408 153 69 144 67 
H-negative risk:  713 662 1078 1082 408 449 103 72 144 153 67 69 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
289 
disease_progression 
H-positive risk:  664 715 73 1071 452 105 1083 408 150 67 145 67 
H-negative risk:  715 664 1083 1071 408 452 105 73 145 150 67 67 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
290 
disease_progression 
H-positive risk:  668 724 74 1077 443 99 1083 403 155 65 143 66 
H-negative risk:  724 668 1083 1077 403 443 99 74 143 155 66 65 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
291 
disease_progression 
H-positive risk:  667 723 75 1071 437 101 1091 414 154 62 140 65 
H-negative risk:  723 667 1091 1071 414 437 101 75 140 154 65 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
292 
disease_progression 
H-positive risk:  670 717 77 1078 438 103 1083 412 151 65 142 64 
H-negative risk:  717 670 1083 1078 412 438 103 77 142 151 64 65 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
293 
disease_progression 
H-positive risk:  671 718 77 1083 432 102 1082 410 152 65 143 65 
H-negative risk:  718 671 1082 1083 410 432 102 77 143 152 65 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 91 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
294 
disease_progression 
H-positive risk:  679 725 78 1075 429 104 1079 406 152 66 140 67 
H-negative risk:  725 679 1079 1075 406 429 104 78 140 152 67 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
295 
disease_progression 
H-positive risk:  672 726 78 1076 431 102 1083 407 152 67 141 65 
H-negative risk:  726 672 1083 1076 407 431 102 78 141 152 65 67 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
296 
disease_progression 
H-positive risk:  671 720 78 1081 434 104 1092 398 151 65 142 64 
H-negative risk:  720 671 1092 1081 398 434 104 78 142 151 64 65 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
297 
disease_progression 
H-positive risk:  668 723 78 1077 439 106 1101 395 149 62 142 60 
H-negative risk:  723 668 1101 1077 395 439 106 78 142 149 60 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
298 
disease_progression 
H-positive risk:  672 731 80 1079 434 104 1092 393 149 61 142 63 
H-negative risk:  731 672 1092 1079 393 434 104 80 142 149 63 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
299 
disease_progression 
H-positive risk:  674 734 79 1077 434 106 1092 392 151 58 139 64 
H-negative risk:  734 674 1092 1077 392 434 106 79 139 151 64 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
300 
disease_progression 
H-positive risk:  665 738 81 1074 436 104 1100 394 150 58 135 65 
H-negative risk:  738 665 1100 1074 394 436 104 81 135 150 65 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
301 
disease_progression 
H-positive risk:  667 737 78 1081 424 108 1101 397 149 55 137 66 
H-negative risk:  737 667 1101 1081 397 424 108 78 137 149 66 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
302 
disease_progression 
H-positive risk:  663 732 81 1082 423 105 1092 410 150 55 139 68 
H-negative risk:  732 663 1092 1082 410 423 105 81 139 150 68 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
303 
disease_progression 
H-positive risk:  666 739 81 1081 420 106 1092 405 151 54 139 66 
H-negative risk:  739 666 1092 1081 405 420 106 81 139 151 66 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
304 
disease_progression 
H-positive risk:  668 732 82 1080 421 105 1095 405 154 56 137 65 
H-negative risk:  732 668 1095 1080 405 421 105 82 137 154 65 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
305 
disease_progression 
H-positive risk:  669 737 81 1082 413 106 1090 410 155 55 137 65 
H-negative risk:  737 669 1090 1082 410 413 106 81 137 155 65 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
306 
disease_progression 
H-positive risk:  667 739 80 1088 409 105 1097 404 153 57 135 66 
H-negative risk:  739 667 1097 1088 404 409 105 80 135 153 66 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
307 
disease_progression 
H-positive risk:  663 739 80 1077 412 107 1105 406 158 56 135 62 
H-negative risk:  739 663 1105 1077 406 412 107 80 135 158 62 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
308 
disease_progression 
H-positive risk:  660 739 78 1069 428 108 1102 402 160 58 137 59 
H-negative risk:  739 660 1102 1069 402 428 108 78 137 160 59 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
309 
disease_progression 
H-positive risk:  655 747 77 1060 428 108 1105 403 161 58 138 60 
H-negative risk:  747 655 1105 1060 403 428 108 77 138 161 60 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
310 
disease_progression 
H-positive risk:  660 747 80 1060 429 107 1098 399 163 57 138 62 
H-negative risk:  747 660 1098 1060 399 429 107 80 138 163 62 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
311 
disease_progression 
H-positive risk:  668 745 78 1052 427 110 1100 400 160 59 140 61 
H-negative risk:  745 668 1100 1052 400 427 110 78 140 160 61 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
91 new agents 
312 
disease_progression 
H-positive risk:  667 747 78 1050 420 112 1106 400 161 57 142 60 
H-negative risk:  747 667 1106 1050 400 420 112 78 142 161 60 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 81 36 

clinical_engagement 
diagnosis 
demography 
94 new agents 
313 
disease_progression 
H-positive risk:  675 750 76 1065 404 109 1102 400 162 54 141 62 
H-negative risk:  750 675 1102 1065 400 404 109 76 141 162 62 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
92 new agents 
314 
disease_progression 
H-positive risk:  669 757 79 1059 397 111 1108 401 162 56 141 60 
H-negative risk:  757 669 1108 1059 401 397 111 79 141 162 60 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
315 
disease_progression 
H-positive risk:  663 754 77 1075 394 111 1100 400 168 56 143 59 
H-negative risk:  754 663 1100 1075 400 394 111 77 143 168 59 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
101 new agents 
316 
disease_progression 
H-positive risk:  671 760 79 1061 393 107 1095 405 167 55 145 62 
H-negative risk:  760 671 1095 1061 405 393 107 79 145 167 62 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 75 34 

clinical_engagement 
diagnosis 
demography 
71 new agents 
317 
disease_progression 
H-positive risk:  676 756 77 1063 393 103 1097 398 170 58 145 64 
H-negative risk:  756 676 1097 1063 398 393 103 77 145 170 64 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
318 
disease_progression 
H-positive risk:  677 753 76 1054 395 102 1091 407 174 59 147 65 
H-negative risk:  753 677 1091 1054 407 395 102 76 147 174 65 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
319 
disease_progression 
H-positive risk:  679 753 76 1055 397 104 1091 406 170 59 145 65 
H-negative risk:  753 679 1091 1055 406 397 104 76 145 170 65 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
68 new agents 
320 
disease_progression 
H-positive risk:  671 761 79 1045 400 105 1094 406 170 61 143 65 
H-negative risk:  761 671 1094 1045 406 400 105 79 143 170 65 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
48 new agents 
321 
disease_progression 
H-positive risk:  666 751 79 1052 404 102 1097 410 172 60 141 66 
H-negative risk:  751 666 1097 1052 410 404 102 79 141 172 66 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
322 
disease_progression 
H-positive risk:  665 739 80 1062 406 102 1094 414 170 63 142 63 
H-negative risk:  739 665 1094 1062 414 406 102 80 142 170 63 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
323 
disease_progression 
H-positive risk:  670 745 81 1055 411 104 1081 418 170 60 144 61 
H-negative risk:  745 670 1081 1055 418 411 104 81 144 170 61 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
324 
disease_progression 
H-positive risk:  669 743 79 1052 411 108 1086 417 163 64 148 60 
H-negative risk:  743 669 1086 1052 417 411 108 79 148 163 60 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
325 
disease_progression 
H-positive risk:  673 730 78 1055 422 107 1090 415 160 63 148 59 
H-negative risk:  730 673 1090 1055 415 422 107 78 148 160 59 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 64 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
326 
disease_progression 
H-positive risk:  674 727 78 1051 431 109 1097 409 158 66 144 56 
H-negative risk:  727 674 1097 1051 409 431 109 78 144 158 56 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 64 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
327 
disease_progression 
H-positive risk:  677 718 78 1059 438 107 1099 407 153 64 145 55 
H-negative risk:  718 677 1099 1059 407 438 107 78 145 153 55 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 65 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
328 
disease_progression 
H-positive risk:  675 716 76 1063 441 107 1093 413 149 65 148 54 
H-negative risk:  716 675 1093 1063 413 441 107 76 148 149 54 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 65 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
329 
disease_progression 
H-positive risk:  670 717 76 1070 430 106 1104 412 150 66 145 54 
H-negative risk:  717 670 1104 1070 412 430 106 76 145 150 54 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 65 36 

clinical_engagement 
diagnosis 
demography 
82 new agents 
330 
disease_progression 
H-positive risk:  666 712 75 1075 428 106 1104 416 152 66 147 53 
H-negative risk:  712 666 1104 1075 416 428 106 75 147 152 53 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 67 36 

clinical_engagement 
diagnosis 
demography 
83 new agents 
331 
disease_progression 
H-positive risk:  678 721 74 1062 438 106 1095 405 154 65 149 53 
H-negative risk:  721 678 1095 1062 405 438 106 74 149 154 53 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 65 36 

clinical_engagement 
diagnosis 
demography 
68 new agents 
332 
disease_progression 
H-positive risk:  681 716 76 1063 437 107 1099 400 154 62 153 52 
H-negative risk:  716 681 1099 1063 400 437 107 76 153 154 52 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 65 36 

clinical_engagement 
diagnosis 
demography 
80 new agents 
333 
disease_progression 
H-positive risk:  684 711 75 1068 437 107 1097 402 155 62 151 51 
H-negative risk:  711 684 1097 1068 402 437 107 75 151 155 51 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 68 37 

clinical_engagement 
diagnosis 
demography 
68 new agents 
334 
disease_progression 
H-positive risk:  688 716 72 1069 441 108 1092 393 152 67 152 50 
H-negative risk:  716 688 1092 1069 393 441 108 72 152 152 50 67 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 67 36 

clinical_engagement 
diagnosis 
demography 
82 new agents 
335 
disease_progression 
H-positive risk:  687 712 74 1075 441 107 1085 397 153 69 151 49 
H-negative risk:  712 687 1085 1075 397 441 107 74 151 153 49 69 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 68 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
336 
disease_progression 
H-positive risk:  702 714 76 1076 435 106 1084 390 152 66 150 49 
H-negative risk:  714 702 1084 1076 390 435 106 76 150 152 49 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 70 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
337 
disease_progression 
H-positive risk:  703 717 76 1069 431 103 1087 400 151 63 152 48 
H-negative risk:  717 703 1087 1069 400 431 103 76 152 151 48 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 74 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
338 
disease_progression 
H-positive risk:  706 718 75 1073 425 105 1093 392 150 63 154 46 
H-negative risk:  718 706 1093 1073 392 425 105 75 154 150 46 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 72 37 

clinical_engagement 
diagnosis 
demography 
78 new agents 
339 
disease_progression 
H-positive risk:  712 716 79 1073 417 108 1096 392 146 60 152 49 
H-negative risk:  716 712 1096 1073 392 417 108 79 152 146 49 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 70 38 

clinical_engagement 
diagnosis 
demography 
87 new agents 
340 
disease_progression 
H-positive risk:  709 723 81 1065 409 107 1104 398 148 59 150 47 
H-negative risk:  723 709 1104 1065 398 409 107 81 150 148 47 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 70 41 

clinical_engagement 
diagnosis 
demography 
73 new agents 
341 
disease_progression 
H-positive risk:  706 722 80 1066 416 108 1097 396 147 62 151 49 
H-negative risk:  722 706 1097 1066 396 416 108 80 151 147 49 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 69 42 

clinical_engagement 
diagnosis 
demography 
77 new agents 
342 
disease_progression 
H-positive risk:  698 725 81 1077 414 106 1098 393 148 61 148 51 
H-negative risk:  725 698 1098 1077 393 414 106 81 148 148 51 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 71 42 

clinical_engagement 
diagnosis 
demography 
70 new agents 
343 
disease_progression 
H-positive risk:  700 720 79 1089 414 106 1096 389 144 63 148 52 
H-negative risk:  720 700 1096 1089 389 414 106 79 148 144 52 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 73 42 

clinical_engagement 
diagnosis 
demography 
70 new agents 
344 
disease_progression 
H-positive risk:  694 717 78 1097 411 107 1095 394 144 62 149 52 
H-negative risk:  717 694 1095 1097 394 411 107 78 149 144 52 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 71 43 

clinical_engagement 
diagnosis 
demography 
81 new agents 
345 
disease_progression 
H-positive risk:  691 713 76 1098 414 109 1105 388 144 63 146 53 
H-negative risk:  713 691 1105 1098 388 414 109 76 146 144 53 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 73 43 

clinical_engagement 
diagnosis 
demography 
76 new agents 
346 
disease_progression 
H-positive risk:  687 718 79 1094 426 108 1102 382 142 62 148 52 
H-negative risk:  718 687 1102 1094 382 426 108 79 148 142 52 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 76 42 

clinical_engagement 
diagnosis 
demography 
77 new agents 
347 
disease_progression 
H-positive risk:  688 722 79 1092 420 107 1111 383 142 62 145 49 
H-negative risk:  722 688 1111 1092 383 420 107 79 145 142 49 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 75 43 

clinical_engagement 
diagnosis 
demography 
75 new agents 
348 
disease_progression 
H-positive risk:  688 725 79 1098 416 110 1105 381 140 63 145 50 
H-negative risk:  725 688 1105 1098 381 416 110 79 145 140 50 63 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 75 44 

clinical_engagement 
diagnosis 
demography 
72 new agents 
349 
disease_progression 
H-positive risk:  687 714 81 1101 414 114 1107 387 135 65 143 52 
H-negative risk:  714 687 1107 1101 387 414 114 81 143 135 52 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 76 41 

clinical_engagement 
diagnosis 
demography 
82 new agents 
350 
disease_progression 
H-positive risk:  679 719 81 1101 411 111 1115 383 137 64 144 55 
H-negative risk:  719 679 1115 1101 383 411 111 81 144 137 55 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 74 41 

clinical_engagement 
diagnosis 
demography 
69 new agents 
351 
disease_progression 
H-positive risk:  678 718 81 1097 419 111 1107 394 135 65 140 55 
H-negative risk:  718 678 1107 1097 394 419 111 81 140 135 55 65 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 72 39 

clinical_engagement 
diagnosis 
demography 
79 new agents 
352 
disease_progression 
H-positive risk:  682 717 81 1101 415 108 1113 391 135 63 139 55 
H-negative risk:  717 682 1113 1101 391 415 108 81 139 135 55 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
72 new agents 
353 
disease_progression 
H-positive risk:  683 718 80 1102 414 108 1118 391 135 59 137 55 
H-negative risk:  718 683 1118 1102 391 414 108 80 137 135 55 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
77 new agents 
354 
disease_progression 
H-positive risk:  677 720 82 1115 415 103 1111 396 134 59 137 51 
H-negative risk:  720 677 1111 1115 396 415 103 82 137 134 51 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 71 36 

clinical_engagement 
diagnosis 
demography 
86 new agents 
355 
disease_progression 
H-positive risk:  677 724 86 1114 408 104 1115 396 132 58 133 53 
H-negative risk:  724 677 1115 1114 396 408 104 86 133 132 53 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 71 35 

clinical_engagement 
diagnosis 
demography 
74 new agents 
356 
disease_progression 
H-positive risk:  681 723 86 1116 404 106 1108 398 132 58 134 54 
H-negative risk:  723 681 1108 1116 398 404 106 86 134 132 54 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 72 37 

clinical_engagement 
diagnosis 
demography 
69 new agents 
357 
disease_progression 
H-positive risk:  681 721 87 1117 397 108 1114 399 131 60 132 53 
H-negative risk:  721 681 1114 1117 399 397 108 87 132 131 53 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 71 36 

clinical_engagement 
diagnosis 
demography 
67 new agents 
358 
disease_progression 
H-positive risk:  681 720 87 1115 401 107 1118 397 131 55 137 51 
H-negative risk:  720 681 1118 1115 397 401 107 87 137 131 51 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 69 36 

clinical_engagement 
diagnosis 
demography 
64 new agents 
359 
disease_progression 
H-positive risk:  676 722 89 1103 403 107 1129 393 132 56 140 50 
H-negative risk:  722 676 1129 1103 393 403 107 89 140 132 50 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
96 new agents 
360 
disease_progression 
H-positive risk:  674 718 90 1104 411 107 1126 391 132 58 142 47 
H-negative risk:  718 674 1126 1104 391 411 107 90 142 132 47 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 74 36 

clinical_engagement 
diagnosis 
demography 
71 new agents 
Time difference of 17.163 mins
This is task 5
